PT - JOURNAL ARTICLE AU - Robinson, Kelsey AU - Parrish, Randy AU - Adeyemo, Wasiu Lanre AU - Beaty, Terri H. AU - Butali, Azeez AU - Buxó, Carmen J. AU - Gowans, Lord JJ AU - Hecht, Jacqueline T. AU - Moreno, Lina AU - Murray, Jeffrey C. AU - Shaw, Gary M. AU - Weinberg, Seth M. AU - Brand, Harrison AU - Marazita, Mary L. AU - Cutler, David J. AU - Epstein, Michael P. AU - Yang, Jingjing AU - Leslie, Elizabeth J. TI - Genome-wide study of gene-by-sex interactions identifies risks for cleft palate AID - 10.1101/2024.05.01.24306701 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.01.24306701 4099 - http://medrxiv.org/content/early/2024/05/03/2024.05.01.24306701.short 4100 - http://medrxiv.org/content/early/2024/05/03/2024.05.01.24306701.full AB - Structural birth defects affect 3-4% of all live births and, depending on the type, tend to manifest in a sex-biased manner. Orofacial clefts (OFCs) are the most common craniofacial structural birth defects and are often divided into cleft lip with or without cleft palate (CL/P) and cleft palate only (CP). Previous studies have found sex-specific risks for CL/P, but these risks have yet to be evaluated in CP. CL/P is more common in males and CP is more frequently observed in females, so we hypothesized there would also be sex-specific differences for CP. Using a trio-based cohort, we performed sex-stratified genome-wide association studies (GWAS) based on proband sex followed by a genome-wide gene-by-sex (GxS) interaction testing. There were 13 loci significant for GxS interactions, with the top finding in LTBP1 (RR=3.37 [2.04 - 5.56], p=1.93x10-6). LTBP1 plays a role in regulating TGF-B bioavailability, and knockdown in both mice and zebrafish lead to craniofacial anomalies. Further, there is evidence for differential expression of LTBP1 between males and females in both mice and humans. Therefore, we tested the association between the imputed genetically regulated gene expression of genes with significant GxS interactions and the CP phenotype. We found significant association for LTBP1 in cell cultured fibroblasts in female probands (p=0.0013) but not in males. Taken altogether, we show there are sex-specific risks for CP that are otherwise undetectable in a combined sex cohort, and LTBP1 is a candidate risk gene, particularly in females.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPatient recruitment, assembly of phenotypic information, sequencing services, and data analysis were supported by National Institutes of Health (NIH) grants: X01-HG010835 (EL), R01-DE016148 (MM, SW), R01-DE030342 (EL), R01-DE011931 (JH), R01-DE028300 (AB), R01-DE014581 (TB), R37-DE008559 (JM), R00-DE024571 (CB), S21-MD001830 (CB) U54-GM133807 (CB), T32-GM008490 (KR), F31-DE032588 (KR). This work was in part supported through cooperative agreements under PA 96043 from the Centers for Disease Control and Prevention to the Centers for Birth Defects Research and Prevention participating in the National Birth Defect Prevention Study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional review boards of University of Iowa, University of Pittsburgh, and Emory University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSequence and phenotype data is available from the Database of Genotypes and Phenotypes (dbGaP) under study accession phs002220.v1.p1.